학술논문
PCR200 Content Validity of FACT-GP5 to Assess Treatment Tolerability in Participants With Progressive, Advanced, Kinase Inhibitor-Naïve, RET-Mutant Medullary Thyroid Cancer: Qualitative Interview Sub-Study of the LIBRETTO-531 Trial
Document Type
Abstract
Author
Source
In Value in Health June 2024 27(6) Supplement:S333-S334
Subject
Language
ISSN
1098-3015